10x Genomics appoints Ansuman Satpathy and Joseph Gilliam to board
TXG•10x Genomics appointed Ansuman Satpathy and Joseph Gilliam as Class III directors, effective October 28, 2026, with terms through the 2028 annual shareholder meeting. Gilliam was named chair of the Audit Committee on October 30.
1. Board appointments
10x Genomics appointed Ansuman Satpathy and Joseph Gilliam as Class III directors on October 28, 2026, with their terms running through the 2028 annual shareholder meeting. Gilliam became chair of the board’s Audit Committee on October 30. Satpathy is a Stanford associate professor and former scientific adviser to the company; Gilliam is president and chief operating officer of Glaukos.
